0 Beoordelingen

ID

17577

Beschrijving

NCT00428090 / GSK-AVA105640 A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1)

Trefwoorden

  1. 11-09-16 11-09-16 -
  2. 11-09-16 11-09-16 -
  3. 25-09-16 25-09-16 -
Geüploaded op

25 september 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC-ND 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :


    Geen commentaren

    U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

    REFLECT-1 Visit 3 NCT00428090

    REFLECT-1 Visit 3 NCT00428090

    Patient Information
    Beschrijving

    Patient Information

    Alias
    UMLS CUI-1
    C1955348
    Subject Identifier
    Beschrijving

    Patient Study ID

    Datatype

    text

    Alias
    UMLS CUI [1]
    C2348585
    Visit Date
    Beschrijving

    Visit Date

    Datatype

    date

    Maateenheden
    • dd/MMM/yy
    Alias
    UMLS CUI [1]
    C1320303
    dd/MMM/yy
    Investigator Instructions
    Beschrijving

    Investigator Instructions

    Alias
    UMLS CUI-1
    C1442085
    Telephone the IVRS system to register the visit. (Note that if the subject is not continuiing in the study, you should make a Withdrawal call rather than a Visit Registration call). Review study medication compliance.
    Beschrijving

    Investigator Instructions

    Datatype

    text

    Alias
    UMLS CUI [1]
    C1442085
    Subject Continuation
    Beschrijving

    Subject Continuation

    Alias
    UMLS CUI-1
    C0805733
    If the subject is not continuing in the study, complete all assessments and ensure that all sections of the CRF (including the Study Conclusion section) are completed appropriately. Schedule an early withdrawal follow-up visit for 14 +/- 7 days after thsi visit.
    Beschrijving

    Subject Continuation

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0805733
    Vital signs
    Beschrijving

    Vital signs

    Alias
    UMLS CUI-1
    C0518766
    Weight
    Beschrijving

    Weight

    Datatype

    float

    Maateenheden
    • kg
    Alias
    UMLS CUI [1]
    C0005910
    kg
    Systolic Blood Pressure. Blood Pressure and heart rate will be measured once, after the subject sits queitly for at least 5 minutes.
    Beschrijving

    Systolic Blood Pressure

    Datatype

    float

    Maateenheden
    • mmHg
    Alias
    UMLS CUI [1]
    C0871470
    mmHg
    Diastolic Blood Pressure. Blood Pressure and heart rate will be measured once, after the subject sits queitly for at least 5 minutes.
    Beschrijving

    Diastolic Blood Pressure

    Datatype

    float

    Maateenheden
    • mmHg
    Alias
    UMLS CUI [1]
    C0428883
    mmHg
    Patient Position: Sitting. Blood Pressure and heart rate will be measured once, after the subject sits queitly for at least 5 minutes.
    Beschrijving

    Patient Position

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0449850
    Heart rate. Blood Pressure and heart rate will be measured once, after the subject sits queitly for at least 5 minutes.
    Beschrijving

    Heart Rate

    Datatype

    float

    Maateenheden
    • Beats/Min
    Alias
    UMLS CUI [1]
    C0018810
    Beats/Min
    Central Laboratory (Non Fasting Samples)
    Beschrijving

    Central Laboratory (Non Fasting Samples)

    Alias
    UMLS CUI-1
    C1880016
    Dates sample taken
    Beschrijving

    Dates sample taken

    Datatype

    date

    Maateenheden
    • dd/MMM/yy
    Alias
    UMLS CUI [1]
    C0460065
    dd/MMM/yy
    Concomitant medication
    Beschrijving

    Concomitant medication

    Alias
    UMLS CUI-1
    C2347852
    Record any changes to the subject's concomitant medications or any new medications taken since the last visit in the apporpriate Concomitant Medications sections.
    Beschrijving

    Concomitant medication

    Datatype

    text

    Alias
    UMLS CUI [1]
    C2347852
    Adverse Event
    Beschrijving

    Adverse Event

    Alias
    UMLS CUI-1
    C0877248
    Record details of any new non-serious adverse events/serious adverse events observed or reported by the subject or any changes to ongoing non-serious adverse events in the appropriate Non-Serious Adverse Events/ Serious Adverse Events section.
    Beschrijving

    Adverse Event

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0877248
    Physical Examination
    Beschrijving

    Physical Examination

    Alias
    UMLS CUI-1
    C0031809
    Perform a physical examination on the subject, including auscultation of heart and lungs. Note: If any abnormalities are found as a result of the physical examination, these must be recorded on the Non-Serious Adverse Events page.
    Beschrijving

    Physical Examination

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0031809
    Pedal Oedema
    Beschrijving

    Pedal Oedema

    Alias
    UMLS CUI-1
    C0574002
    Press firmly with thumb anterior to the worst affected ankle until further pressure produces no greater indentation. Visually estimate depth of pit and record the Estimated Depth of Indentation below. Note: Use the same ankle thoughout the study. Tick one:
    Beschrijving

    Pedal Oedema: depth

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0574002
    UMLS CUI [1,2]
    C0205125
    Press firmly with thumb anterior to the worst affected ankle until further pressure produces no greater indentation. Visually estimate depth of pit and record the Estimated Depth of Indentation below. Note: Use the same ankle thoughout the study. Tick the appropriate box below to indicate which ankle was assessed at this visit:
    Beschrijving

    Pedal Oedema: Site

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0574002
    UMLS CUI [1,2]
    C1515974
    Investigational Product - dispense (for Visit 3: Weeks 5 - 8; for Visit 4: Weeks 9 -16; for Visit 5: weeks 17 - 24) study medication as specified by the IVRS system. Record start date, container number and number of tablets dispensed below (stop date and tablets returned will be completed when the bottle is returned)
    Beschrijving

    Investigational Product - dispense (for Visit 3: Weeks 5 - 8; for Visit 4: Weeks 9 -16; for Visit 5: weeks 17 - 24) study medication as specified by the IVRS system. Record start date, container number and number of tablets dispensed below (stop date and tablets returned will be completed when the bottle is returned)

    Alias
    UMLS CUI-1
    C0304229
    Investigational Product (e.g Bottle 1)
    Beschrijving

    Investigational Product

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0304229
    Start Date
    Beschrijving

    Start Date

    Datatype

    date

    Maateenheden
    • dd/MMM/yy
    Alias
    UMLS CUI [1]
    C0808070
    dd/MMM/yy
    Stop Date
    Beschrijving

    Stop Date

    Datatype

    date

    Maateenheden
    • dd/MMM/yy
    Alias
    UMLS CUI [1]
    C0806020
    dd/MMM/yy
    Dose
    Beschrijving

    Dose

    Datatype

    float

    Maateenheden
    • mg
    Alias
    UMLS CUI [1]
    C3174092
    mg
    IP Container No.
    Beschrijving

    IP Container No.

    Datatype

    float

    Alias
    UMLS CUI [1]
    C0180098
    Has the subject missed investigational product for > 7 consecutive days?
    Beschrijving

    Discontinuation

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0457454
    Compliance - dispense (for Visit 3: Weeks 5 - 8; for Visit 4: Weeks 9 -16; for Visit 5: weeks 17 - 24) study medication as specified by the IVRS system. Record start date, container number and number of tablets dispensed below (stop date and tablets returned will be completed when the bottle is returned)
    Beschrijving

    Compliance - dispense (for Visit 3: Weeks 5 - 8; for Visit 4: Weeks 9 -16; for Visit 5: weeks 17 - 24) study medication as specified by the IVRS system. Record start date, container number and number of tablets dispensed below (stop date and tablets returned will be completed when the bottle is returned)

    Alias
    UMLS CUI-1
    C1321605
    Total number of Tablets Dispensed
    Beschrijving

    Total number of Tablets Dispensed

    Datatype

    float

    Alias
    UMLS CUI [1,1]
    C0805077
    UMLS CUI [1,2]
    C0039225
    Total number of Tablets Returned
    Beschrijving

    Total number of Tablets Returned

    Datatype

    float

    Alias
    UMLS CUI [1,1]
    C2699071
    UMLS CUI [1,2]
    C0039225
    End of Visit Reminder
    Beschrijving

    End of Visit Reminder

    Alias
    UMLS CUI-1
    C1709896
    UMLS CUI-2
    C1320303
    Schedule Visit 4 for 4 weeks (+- 3 days) after this visit. It is not necessary for the subject to be fasted.
    Beschrijving

    End of Visit Reminder

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C1709896
    UMLS CUI [1,2]
    C1320303

    Similar models

    REFLECT-1 Visit 3 NCT00428090

    Name
    Type
    Description | Question | Decode (Coded Value)
    Datatype
    Alias
    Item Group
    Patient Information
    C1955348 (UMLS CUI-1)
    Patient Study ID
    Item
    Subject Identifier
    text
    C2348585 (UMLS CUI [1])
    Visit Date
    Item
    Visit Date
    date
    C1320303 (UMLS CUI [1])
    Item Group
    Investigator Instructions
    C1442085 (UMLS CUI-1)
    Investigator Instructions
    Item
    Telephone the IVRS system to register the visit. (Note that if the subject is not continuiing in the study, you should make a Withdrawal call rather than a Visit Registration call). Review study medication compliance.
    text
    C1442085 (UMLS CUI [1])
    Item Group
    Subject Continuation
    C0805733 (UMLS CUI-1)
    Subject Continuation
    Item
    If the subject is not continuing in the study, complete all assessments and ensure that all sections of the CRF (including the Study Conclusion section) are completed appropriately. Schedule an early withdrawal follow-up visit for 14 +/- 7 days after thsi visit.
    text
    C0805733 (UMLS CUI [1])
    Item Group
    Vital signs
    C0518766 (UMLS CUI-1)
    Weight
    Item
    Weight
    float
    C0005910 (UMLS CUI [1])
    Systolic Blood Pressure
    Item
    Systolic Blood Pressure. Blood Pressure and heart rate will be measured once, after the subject sits queitly for at least 5 minutes.
    float
    C0871470 (UMLS CUI [1])
    Diastolic Blood Pressure
    Item
    Diastolic Blood Pressure. Blood Pressure and heart rate will be measured once, after the subject sits queitly for at least 5 minutes.
    float
    C0428883 (UMLS CUI [1])
    Patient Position
    Item
    Patient Position: Sitting. Blood Pressure and heart rate will be measured once, after the subject sits queitly for at least 5 minutes.
    boolean
    C0449850 (UMLS CUI [1])
    Heart Rate
    Item
    Heart rate. Blood Pressure and heart rate will be measured once, after the subject sits queitly for at least 5 minutes.
    float
    C0018810 (UMLS CUI [1])
    Item Group
    Central Laboratory (Non Fasting Samples)
    C1880016 (UMLS CUI-1)
    Dates sample taken
    Item
    Dates sample taken
    date
    C0460065 (UMLS CUI [1])
    Item Group
    Concomitant medication
    C2347852 (UMLS CUI-1)
    Concomitant medication
    Item
    Record any changes to the subject's concomitant medications or any new medications taken since the last visit in the apporpriate Concomitant Medications sections.
    text
    C2347852 (UMLS CUI [1])
    Item Group
    Adverse Event
    C0877248 (UMLS CUI-1)
    Adverse Event
    Item
    Record details of any new non-serious adverse events/serious adverse events observed or reported by the subject or any changes to ongoing non-serious adverse events in the appropriate Non-Serious Adverse Events/ Serious Adverse Events section.
    text
    C0877248 (UMLS CUI [1])
    Item Group
    Physical Examination
    C0031809 (UMLS CUI-1)
    Physical Examination
    Item
    Perform a physical examination on the subject, including auscultation of heart and lungs. Note: If any abnormalities are found as a result of the physical examination, these must be recorded on the Non-Serious Adverse Events page.
    text
    C0031809 (UMLS CUI [1])
    Item Group
    Pedal Oedema
    C0574002 (UMLS CUI-1)
    Pedal Oedema: depth
    Item
    Press firmly with thumb anterior to the worst affected ankle until further pressure produces no greater indentation. Visually estimate depth of pit and record the Estimated Depth of Indentation below. Note: Use the same ankle thoughout the study. Tick one:
    text
    C0574002 (UMLS CUI [1,1])
    C0205125 (UMLS CUI [1,2])
    Item
    Press firmly with thumb anterior to the worst affected ankle until further pressure produces no greater indentation. Visually estimate depth of pit and record the Estimated Depth of Indentation below. Note: Use the same ankle thoughout the study. Tick the appropriate box below to indicate which ankle was assessed at this visit:
    text
    C0574002 (UMLS CUI [1,1])
    C1515974 (UMLS CUI [1,2])
    Code List
    Press firmly with thumb anterior to the worst affected ankle until further pressure produces no greater indentation. Visually estimate depth of pit and record the Estimated Depth of Indentation below. Note: Use the same ankle thoughout the study. Tick the appropriate box below to indicate which ankle was assessed at this visit:
    CL Item
    Right Ankle (Right Ankle)
    CL Item
    Left Ankle (Left Ankle)
    Item Group
    Investigational Product - dispense (for Visit 3: Weeks 5 - 8; for Visit 4: Weeks 9 -16; for Visit 5: weeks 17 - 24) study medication as specified by the IVRS system. Record start date, container number and number of tablets dispensed below (stop date and tablets returned will be completed when the bottle is returned)
    C0304229 (UMLS CUI-1)
    Investigational Product
    Item
    Investigational Product (e.g Bottle 1)
    text
    C0304229 (UMLS CUI [1])
    Start Date
    Item
    Start Date
    date
    C0808070 (UMLS CUI [1])
    Stop Date
    Item
    Stop Date
    date
    C0806020 (UMLS CUI [1])
    Dose
    Item
    Dose
    float
    C3174092 (UMLS CUI [1])
    IP Container No.
    Item
    IP Container No.
    float
    C0180098 (UMLS CUI [1])
    Discontinuation
    Item
    Has the subject missed investigational product for > 7 consecutive days?
    boolean
    C0457454 (UMLS CUI [1])
    Item Group
    Compliance - dispense (for Visit 3: Weeks 5 - 8; for Visit 4: Weeks 9 -16; for Visit 5: weeks 17 - 24) study medication as specified by the IVRS system. Record start date, container number and number of tablets dispensed below (stop date and tablets returned will be completed when the bottle is returned)
    C1321605 (UMLS CUI-1)
    Total number of Tablets Dispensed
    Item
    Total number of Tablets Dispensed
    float
    C0805077 (UMLS CUI [1,1])
    C0039225 (UMLS CUI [1,2])
    Total number of Tablets Returned
    Item
    Total number of Tablets Returned
    float
    C2699071 (UMLS CUI [1,1])
    C0039225 (UMLS CUI [1,2])
    Item Group
    End of Visit Reminder
    C1709896 (UMLS CUI-1)
    C1320303 (UMLS CUI-2)
    End of Visit Reminder
    Item
    Schedule Visit 4 for 4 weeks (+- 3 days) after this visit. It is not necessary for the subject to be fasted.
    text
    C1709896 (UMLS CUI [1,1])
    C1320303 (UMLS CUI [1,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial